Correlation Between Gilead Sciences and CalciMedica, Common

Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gilead Sciences and CalciMedica, Common Stock, you can compare the effects of market volatilities on Gilead Sciences and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and CalciMedica, Common.

Diversification Opportunities for Gilead Sciences and CalciMedica, Common

-0.61

Correlation Coefficient

Gilead Sciences  CalciMedica, Common

Excellent diversification

The 3 months correlation between Gilead and CalciMedica, is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and CalciMedica, Common go up and down completely randomly.

Pair Corralation between Gilead Sciences and CalciMedica, Common

Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.85 times less return on investment than CalciMedica, Common. But when comparing it to its historical volatility, Gilead Sciences is 4.33 times less risky than CalciMedica, Common. It trades about 0.05 of its potential returns per unit of risk. CalciMedica, Common Stock is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  401.00  in CalciMedica, Common Stock on October 22, 2024 and sell it today you would lose (92.00) from holding CalciMedica, Common Stock or give up 22.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Gilead Sciences  vs.  CalciMedica, Common Stock

Gilead Sciences

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound essential indicators, Gilead Sciences is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

CalciMedica, Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Gilead Sciences and CalciMedica, Common

The main advantage of trading using opposite Gilead Sciences and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.

The idea behind Gilead Sciences and CalciMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.